Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial

BACKGROUND: Systemic morphine has evidence to support its use for reducing breathlessness in patients with severe chronic obstructive pulmonary disease (COPD). The effectiveness of the nebulized route, however, has not yet been confirmed. Recent studies have shown that opioid receptors are localized...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Pulm Med
Autors principals: Janowiak, Piotr, Krajnik, Małgorzata, Podolec, Zygmunt, Bandurski, Tomasz, Damps-Konstańska, Iwona, Sobański, Piotr, Currow, David C., Jassem, Ewa
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725796/
https://ncbi.nlm.nih.gov/pubmed/29228935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-017-0535-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars